NCT01300611 - TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Double Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic SyndromeMyelofibrosisAcute Lymphoblastic LeukemiaChronic Myelocytic LeukemiaNon Hodgkins LymphomaHodgkins LymphomaChronic Lymphocytic Leukemia

Interventions

DRUG

TXA127 300 mcg/kg/day

Injection, 300 mcg/kg/day for 28 days

DRUG

TXA127 1000 mcg/kg/day

Injection, 1000 mcg/kg/day for 28 days

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston